Access to HIV preventive drugs sees boost

The Centers for Disease Control and Prevention (CDC) released preliminary data that found 36 percent of people who could benefit from taking PrEP received a prescription in 2022.

Disparities continue to be observed, however. A significantly higher proportion of white people who could benefit from PrEP received a prescription when compared to people of color.